Emerging Technologies for Early Detection of Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Methods and Technologies Development".
Deadline for manuscript submissions: closed (8 September 2023) | Viewed by 249
Special Issue Editors
Interests: spectroscopy; liquid; biopsy; cancer
Interests: cancer biology; pediatric; Fos–Jun oncogene junction; signal transduction
Special Issue Information
Dear Colleagues,
The early detection of cancer is paramount in enabling improvements in patient survival and quality of life. Detection of cancer can be performed at may stages throughout the patient’s pathway, either in screening primary care populations for early detection, in symptomatic populations to triage from diseases that have similar symptoms, speeding up the interpretation of imaging, and identifying diseases that will respond to particular targeted treatments. To tackle this suite of early detection stages, there is a plethora of research across many disciplines being performed by interdisciplinary teams across the globe.
This Special edition Issue aims to highlight research, both basic and translational, that can enable the future of cancer detection through the release and development of novel technologies. Studies presenting novel technologies that enable new insights and applications of existing technologies in novel ways are welcomed for submission to this Special Issue. We welcome submissions on emerging technologies from genomics, metabolomics, and multi-/pan-omic approaches that can enable access to the full range of information available for the detection and monitoring of cancers in cells, tissues, and bodily fluids.
Prof. Dr. Matthew J. Baker
Prof. Dr. Tom Curran
Prof. Dr. Bhargava Rohit
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
